Design Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep '24 Sep 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Cash & Equivalents	30.33	21.2	26.5	298.57	2.38	0.08
Short-Term Investments	223.75	260.6	303.89	85.5	33.71	-
Cash & Short-Term Investments	254.07	281.8	330.39	384.06	36.09	0.08
Cash Growth	-12.67%	-14.71%	-13.98%	964.15%	46771.43%	-
Other Receivables	1.18	1.43	1.12	0.11	0.01	-
Receivables	1.18	1.43	1.12	0.11	0.01	-
Prepaid Expenses	1.99	1.35	3.62	1.26	0.06	0.01
Other Current Assets	-	-	-	-	0.07	0.01
Total Current Assets	257.24	284.58	335.12	385.44	36.23	0.09
Property, Plant & Equipment	3.96	4.63	5.56	5.12	0.07	-
Long-Term Deferred Charges	-	-	-	-	0.21	-
Other Long-Term Assets	0.43	0.43	0.46	-	-	-
Total Assets	261.63	289.64	341.14	390.56	36.52	0.09
Accounts Payable	1.47	1.94	3.03	1.62	1.4	2.48
Accrued Expenses	5.18	6.97	7.11	3.17	0.93	0.24
Short-Term Debt	-	-	-	-	-	0.7
Current Portion of Leases	0.78	0.72	0.64	0.49	-	-
Current Unearned Revenue	-	-	-	-	-	0.2
Other Current Liabilities	-	-	-	-	-	0.11
Total Current Liabilities	7.43	9.62	10.78	5.28	2.33	3.73
Long-Term Leases	1.74	2.33	3.05	3.14	-	-
Other Long-Term Liabilities	-	-	-	-	0.15	0
Total Liabilities	9.18	11.96	13.83	8.43	2.48	3.73
Common Stock	0.01	0.01	0.01	0.01	0	0
Additional Paid-In Capital	465.1	455.25	441.42	429.82	0.45	-
Retained Earnings	-213.56	-177.63	-110.76	-47.46	-11.92	-3.64
Comprehensive Income & Other	0.91	0.06	-3.36	-0.24	0.16	-
Total Common Equity	252.45	277.69	327.31	382.13	-11.32	-3.64
Shareholders' Equity	252.45	277.69	327.31	382.13	34.04	-3.64
Total Liabilities & Equity	261.63	289.64	341.14	390.56	36.52	0.09
Total Debt	2.52	3.05	3.69	3.63	-	0.7
Net Cash (Debt)	251.55	278.75	326.7	380.43	36.09	-0.62
Net Cash Growth	-12.57%	-14.68%	-14.12%	954.09%	-	-
Net Cash Per Share	4.46	4.98	5.86	8.28	2.28	-0.04
Filing Date Shares Outstanding	56.62	56.49	55.9	55.46	15.96	15.64
Total Common Shares Outstanding	56.62	56.47	55.9	55.44	15.96	15.64
Working Capital	249.81	274.96	324.34	380.15	33.9	-3.64
Book Value Per Share	4.46	4.92	5.86	6.89	-0.71	-0.23
Tangible Book Value	252.45	277.69	327.31	382.13	-11.32	-3.64
Tangible Book Value Per Share	4.46	4.92	5.86	6.89	-0.71	-0.23
Machinery	2.91	2.6	2.32	1.54	0.08	-
Construction In Progress	-	-	-	0.01	-	-
Leasehold Improvements	0.15	0.15	0.15	0.1	-	-

Source: S&P Capital IQ. Standard template. Financial Sources.